Renalytix uses cookies to improve your experience. We respect your privacy and are committed to protecting your personal data. Read Privacy Notice

The Importance of Earlier-Stage Kidney Care and Why PCPs are the Key.

Elise: I know that you’re not personally involved in The UCLA Kidney Health Program but wanted to get your perspective on some of its work on behalf of patients diagnosed with chronic kidney disease (CKD). UCLA describes the program as a multi-discipline effort working to bring new and innovative techniques to a range of kidney… Continue reading The Importance of Earlier-Stage Kidney Care and Why PCPs are the Key.

Published
Categorized as Blog

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

Risk scoring by KidneyIntelX resulted in a 4.5-fold increase in new drug prescriptions (for SGLT2 inhibitors) for high risk compared to low risk patients, an observed reduction of HbA1c levels in the highest risk patients, an overall increased use of antihypertensive therapeutics, and an observed

Read More

Published
Categorized as News

Why we need to remove race from kidney function equations.

Elise: In our first conversation, we acknowledged the recent debates over removing race from kidney function equations. You were a strong proponent of that action. Based on comments we received, our readers want to more deeply understand the context around your position. Can you provide more color for why removing race is so important?  … Continue reading Why we need to remove race from kidney function equations.

Published
Categorized as Blog

Renalytix to Present at Stifel Healthcare Conference

NEW YORK and SALT LAKE CITY, Nov. 03, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will participate in the Stifel Healthcare Conference to be held November 15-16, 2022 at the Lotte New York Palace Hotel.

Read More

Published
Categorized as News

Should race ever play a role in health care?

Introduction As our readers know, the primary reason for the existence of this Well FilteredTM blog is to bring into focus the latest thinking and perspectives, innovations, and methods for promoting and advancing global kidney health. In some of our previous blog posts, we’ve discussed the societal need to address racial, social, behavioral and economic… Continue reading Should race ever play a role in health care?

Published
Categorized as Blog

Renalytix Reports Full Year Fiscal 2022 Results

LONDON and SALT LAKE CITY, Oct. 31, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based

Read More

Published
Categorized as News


Well Filtered™

Get access to the blog, webinars and podcasts with the ideas, perspectives and innovations that matter most in kidney health.